Patent Assignment
Reel/Frame 022692/0384
Assignment of Assignor's Interest
Recorded: 2009-05-15
Pages: 8
Assignors
OCHIYA, TAKAHIRO
Executed: 2008-12-15
KATO, KIKUYA
Executed: 2008-12-24
HONMA, KIMI
Executed: 2008-12-05
UEDA, YASUJI
Executed: 2008-12-01
Assignees
TAISHO PHARMACEUTICAL CO., LTD.
24-1, TAKADA 3-CHOME, TOSHIMA-KU, TOKYO, 170-8633, JAPAN
DAINIPPON SUMITOMO PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-8524, JAPAN
JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CANCER CENTER
1-1, TSUKIJI 5-CHOME, CHUO-KU, TOKYO, 104-0045, JAPAN
KOKEN CO., LTD.
3-14-3, MEJIRO, TOSHIMA-KU, TOKYO, 171-0031, JAPAN
Covered Property
(1)
Method of Treating Cancer with an RPN2 Gene Expression Inhibitor
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Nov 4, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034160/0613 →
Change of Address
Jan 24, 2023
From: SUMITOMO PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 062475/0509 →
Change of Name
Jan 24, 2023
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 063753/0826 →